Abstract
Abstract
Objective
The prevalence of Personality disorders (PD) is high among psychiatric patients who have consulted and have been diagnosed as psychiatric illness. The prevalence of personality disorders (PD) among general population varies as %10-13 and the prevalence of PD among psychiatric outpatients is %30-50 and %15 among inpatients. The most common PDs are regarded as Borderline Personality Disorder (BPD), Antisocial Personality Disorder (APD), Schizotypal Personality Disorder (SPD) and Avoidant Personality Disorder (AvPD). These four disorders may cause impairments in social functioning and professional breakdown, suicidal behavior, substance abuse and cognitive impairment. Patients who have the diagnosis of PD generally apply to primary care and mental health services and the data, which is related to these patients’ use of the medical treatment service opportunity, the increase of medical health care cost and social obligations, has been gradually growing.
The aim of this article is to review double-blind, controlled studies of psychotropic drugs to evaluate the evidence base supporting their use in treatment of personality disorder.
Personality Disorder appearing with different facts and mental disorders does not have a unique treatment and a suitable treatment for patients, clinic symptoms accompanying mental disorders needs to be specially planned. There are numerous psychotropic treatments in Personality Disorder. However, there have been some doubts about the efficiency of them. The aim of this study is to observe the efficiency of psychotropic pharmacologic treatment on PD.
Methods
Literature cited in pubmed published between 1980 and 2011 was searched using the following terms: personality disorder, borderline, antisocial, schizotypal, narsistic, schizoid, obsessive-compulsive, avoidant personality disorder, medication and pharmacotherapy. While reports of double-blind, randomized, controlled trials were included, some open-lable trails have taken account.
Result
The observations are significantly related in BPD treatment. Widely-used multi drug medication in BPD diagnosed patients is regarded as not efficient at all. Mood stabilizator drugs seem to take place of antidepresssant treatment whereas use of antidepresant treatment reduces the affective symptoms, such as severe anger and disphoria which facilitates psychotherapy treatment. Mood stabilizators, especially divalproic asit, is suggested to efficiant on anger dimention of BPD. Results suggest that primer treatment of APD is cognitive behavioral therapy and there is insufficient trial evidence to justify using any pharmacoterapic interventions. Different treatment choices can be developed understanding the etiology of disfunctional emotional empathy in APD, with in progressive neurobiological treatment. It is regarded that antipsychotic treatment is efficent in schizotypal personality disorder that is assesed in schiozophrenia spectrum disord

Key words: Personality disorders, pharmacotherapy, borderline personality disorder